Analysts Conflicted on These Healthcare Names: Neurocrine (NBIX), Vertex Pharmaceuticals (VRTX) and Jasper Therapeutics (JSPR)

TipRanksDec 23 20:10 · Ratings

Jasper Launches AI Studio, Empowering Enterprise Marketing Teams to Build & Scale Generative AI Solutions

PR NewswireDec 16 22:00

Jasper Therapeutics Initiated at Outperform by BMO Capital

Dow JonesDec 6 19:00 · Ratings

Jasper Therapeutics Analyst Ratings

BenzingaDec 6 18:49 · Ratings

BMO Capital Initiates Jasper Therapeutics(JSPR.US) With Buy Rating, Announces Target Price $63

Futu NewsDec 6 05:31 · Ratings

Express News | Jasper Therapeutics Inc - Initial Data Expected in Second Half of 2025

BreakingsDec 3 05:30